Riadh Lobbardi

Riadh Lobbardi is currently the Director of Translational Medicine at C4 Therapeutics, Inc., with previous experience as a Senior Scientist in Translational Medicine at Blueprint Medicines and as a Research Fellow at Massachusetts General Hospital. Riadh has a background in molecular and cellular developmental biology, with a Ph.D. from Université Pierre et Marie Curie (Paris VI) / Ecole Normale Superieure. Their research interests have focused on investigating molecular mechanisms in cancer and muscle formation, particularly in zebrafish models.